These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 8131952)
1. Quantitation of HMG-CoA reductase mRNA levels in peripheral blood mononuclear cells of normal individuals and patients with altered lipoprotein metabolism. Alrokayan SA; Marenah CB; White DA; Billett MA Biochem Soc Trans; 1993 Nov; 21(4):375S. PubMed ID: 8131952 [No Abstract] [Full Text] [Related]
2. Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in human liver. Powell EE; Kroon PA J Clin Invest; 1994 May; 93(5):2168-74. PubMed ID: 8182149 [TBL] [Abstract][Full Text] [Related]
3. In vivo regulation of human mononuclear leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase. Decreased enzyme catalytic efficiency in familial hypercholesterolemia. Stacpoole PW; Bridge DM; Alvarez IM; Goldberg RB; Harwood HJ J Clin Invest; 1987 Nov; 80(5):1401-8. PubMed ID: 2824560 [TBL] [Abstract][Full Text] [Related]
4. Regulation of 3-hydroxy-3-methylglutaryl coenzyme-A reductase activity in type II hyperlipoproteinaemia. Betteridge DJ; Higgins MJ; Galton DJ Br Med J; 1975 Nov; 4(5995):500-2. PubMed ID: 172188 [TBL] [Abstract][Full Text] [Related]
5. Diagnosing familial hypercholesterolaemia in childhood. Betteridge DJ; Galton D; Giggins M Br Med J; 1977 Jul; 2(6079):127. PubMed ID: 871792 [No Abstract] [Full Text] [Related]
6. Validation of using gene expression in mononuclear cells as a marker for hepatic cholesterol metabolism. Aggarwal D; Freake HC; Soliman GA; Dutta A; Fernandez ML Lipids Health Dis; 2006 Aug; 5():22. PubMed ID: 16911794 [TBL] [Abstract][Full Text] [Related]
7. Contribution of increased HMG-CoA reductase gene expression to hypercholesterolemia in experimental chronic renal failure. Chmielewski M; Sucajtys E; Swierczynski J; Rutkowski B; Bogusławski W Mol Cell Biochem; 2003 Apr; 246(1-2):187-91. PubMed ID: 12841361 [TBL] [Abstract][Full Text] [Related]
8. Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia. Gianturco SH; Gotto AM; Jackson RL; Patsch JR; Sybers HD; Taunton OD; Yeshurun DL; Smith LC J Clin Invest; 1978 Feb; 61(2):320-8. PubMed ID: 202612 [TBL] [Abstract][Full Text] [Related]
9. A new type of familial hypercholesterolaemia. Higgins MJ; Lecamwasam DS; Galton DJ Lancet; 1975 Oct; 2(7938):737-40. PubMed ID: 52771 [TBL] [Abstract][Full Text] [Related]
10. Measurement of mRNA by quantitative PCR with a nonradioactive label. Powell EE; Kroon PA J Lipid Res; 1992 Apr; 33(4):609-14. PubMed ID: 1527484 [TBL] [Abstract][Full Text] [Related]
11. Effect of lipoprotein on 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase activity in rat liver cell culture: special suppressant effect of a lipoprotein isolated from hypercholesterolemic rat plasma. Breslow JL; Spaulding DR; Lothrop DA; Clowes AW Biochem Biophys Res Commun; 1975 Nov; 67(1):119-25. PubMed ID: 1201014 [No Abstract] [Full Text] [Related]
13. Regulation of porcine granulosa cell 3-hydroxy-3-methylglutaryl coenzyme A reductase by insulin and insulin-like growth factor I: synergism with follicle-stimulating hormone or protein kinase A agonist. Maitra A; LaVoie HA; Day RN; Garmey JC; Veldhuis JD Endocrinology; 1995 Nov; 136(11):5111-7. PubMed ID: 7588248 [TBL] [Abstract][Full Text] [Related]
14. Plasma lipoproteins and cholesterol metabolism in Yoshida rats: an animal model of spontaneous hyperlipemia. Fantappiè S; Catapano AL; Cancellieri M; Fasoli L; De Fabiani E; Bertolini M; Bosisio E Life Sci; 1992; 50(24):1913-24. PubMed ID: 1598076 [TBL] [Abstract][Full Text] [Related]
15. Low postheparin plasma hepatic lipase activity in familial type IIa hyperlipoproteinemia. Nikkilä EA; Huttunen JK; Ehnholm C Ann Clin Res; 1976 Feb; 8(1):63-7. PubMed ID: 180867 [TBL] [Abstract][Full Text] [Related]
16. Regulation of ovarian cholesterol metabolism: control of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A:cholesterol acyltransferase. Schuler LA; Toaff ME; Strauss JF Endocrinology; 1981 Apr; 108(4):1476-86. PubMed ID: 7472277 [TBL] [Abstract][Full Text] [Related]
18. Regulation by plasma lipoproteins of progesterone biosynthesis and 3-hydroxy-3-methyl glutaryl coenzyme a reductase activity in cultured human choriocarcinoma cells. Simpson ER; Porter JC; Milewich L; Bilheimer DW; MacDonald PC J Clin Endocrinol Metab; 1978 Nov; 47(5):1099-105. PubMed ID: 263339 [TBL] [Abstract][Full Text] [Related]
19. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes. Qin W; Infante J; Wang SR; Infante R Biochim Biophys Acta; 1992 Jul; 1127(1):57-66. PubMed ID: 1627634 [TBL] [Abstract][Full Text] [Related]
20. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia. Broyles FE; Walden CE; Hunninghake DB; Hill-Williams D; Knopp RH Am J Cardiol; 1995 Jul; 76(2):129A-135A. PubMed ID: 7604788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]